BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30027935)

  • 1. [Pathology of lung neuroendocrine tumors].
    Fillinger J
    Magy Onkol; 2018 Jul; 62(2):83-89. PubMed ID: 30027935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
    Schnabel PA; Junker K
    Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.
    Travis WD; Rush W; Flieder DB; Falk R; Fleming MV; Gal AA; Koss MN
    Am J Surg Pathol; 1998 Aug; 22(8):934-44. PubMed ID: 9706973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.
    Travis WD
    Thorac Surg Clin; 2014 Aug; 24(3):257-66. PubMed ID: 25065926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.
    Liu SZ; Staats PN; Goicochea L; Alexiev BA; Shah N; Dixon R; Burke AP
    Diagn Pathol; 2014 Oct; 9():174. PubMed ID: 25318848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.
    Yeh YC; Chou TY
    J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization.
    Walch AK; Zitzelsberger HF; Aubele MM; Mattis AE; Bauchinger M; Candidus S; Präuer HW; Werner M; Höfler H
    Am J Pathol; 1998 Oct; 153(4):1089-98. PubMed ID: 9777940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The surgical spectrum of pulmonary neuroendocrine neoplasms.
    Cooper WA; Thourani VH; Gal AA; Lee RB; Mansour KA; Miller JI
    Chest; 2001 Jan; 119(1):14-8. PubMed ID: 11157578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.
    Travis WD; Linnoila RI; Tsokos MG; Hitchcock CL; Cutler GB; Nieman L; Chrousos G; Pass H; Doppman J
    Am J Surg Pathol; 1991 Jun; 15(6):529-53. PubMed ID: 1709558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of neuroendocrine lung tumor classification.
    Travis WD; Gal AA; Colby TV; Klimstra DS; Falk R; Koss MN
    Hum Pathol; 1998 Mar; 29(3):272-9. PubMed ID: 9496831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchopulmonary neuroendocrine tumors.
    Gustafsson BI; Kidd M; Chan A; Malfertheiner MV; Modlin IM
    Cancer; 2008 Jul; 113(1):5-21. PubMed ID: 18473355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in neuroendocrine lung tumors.
    Travis WD
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii65-71. PubMed ID: 20943645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine neoplasms of the lung: a prognostic spectrum.
    Asamura H; Kameya T; Matsuno Y; Noguchi M; Tada H; Ishikawa Y; Yokose T; Jiang SX; Inoue T; Nakagawa K; Tajima K; Nagai K
    J Clin Oncol; 2006 Jan; 24(1):70-6. PubMed ID: 16382115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine tumors of the lung: clinicopathological and molecular features.
    Iyoda A; Azuma Y; Sano A
    Surg Today; 2020 Dec; 50(12):1578-1584. PubMed ID: 32193632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.
    Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H
    Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous computed tomography-guided core needle biopsy can be used to histologically confirm the clinical features and long-term prognosis of pulmonary neuroendocrine neoplasms.
    Chen C; Wang Y; Huang H; He X; Li W
    Jpn J Radiol; 2023 Dec; 41(12):1414-1419. PubMed ID: 37395983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of the neuroendocrine tumors of the lung].
    Gálffy G
    Magy Onkol; 2018 Jul; 62(2):113-118. PubMed ID: 30027939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
    Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
    Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.